Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Oxford Clinical Trials Research Unit

We would like to make everyone aware that the OCTRU office continues to be contactable during the current situation regarding COVID-19.

If you have any queries please continue to contact us at octrutrialshub@ndorms.ox.ac.uk or for queries about specific trials, please contact the trial teams directly on the numbers on your information sheets or the trial websites.   

OCTRU

ABOUT US      THEMES      TRIALS PORTFOLIO      NEWS      TRAINING      INTERVENTIONS      OUR TEAM      METHODOLOGY RESEARCH      CTU INFOGRAPHICS

Welcome

Welcome to the OCTRU website. The University of Oxford has a long standing tradition in clinical trials and OCTRU based within the University is one of the UKCRC's registered clinical trials units.

Latest News

A plastic skull with a plastic brain inside

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.

Child with a bandaged wrist

Emergency departments to use the FORCE pathway for wrist fractures in children

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Vials of the Covid-19 vaccine

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

The nurses at NDORMS share messages of what Clinical Trials Day means to them

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

NIHR CTU SUPPORT

PLEASE NOTE: This unit receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.

TRAINING SESSIONS & SEMINARS

More events

Would you like to collaborate with OCTRU?

OCTRU welcomes requests to collaborate, look to see which of our themes your collaboration may fit within. 

Find out more